Author:
Tyner J W,Loriaux M M,Erickson H,Eide C A,Deininger J,MacPartlin M,Willis S G,Lange T,Druker B J,Kovacsovics T,Maziarz R,Gattermann N,Deininger M W
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference15 articles.
1. Vardiman JW, Brunning RD, Harris NL . Chronic myeloproliferative diseases. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). Tumors of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2001, pp 15–59.
2. Lauchle JO, Braun BS, Loh ML, Shannon K . Inherited predispositions and hyperactive Ras in myeloid leukemogenesis. Pediatr Blood Cancer 2006; 46: 579–585.
3. Hirsch-Ginsberg C, LeMaistre AC, Kantarjian H, Talpaz M, Cork A, Freireich EJ et al. RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia. Blood 1990; 76: 1214–1219.
4. Loh ML, Martinelli S, Cordeddu V, Reynolds MG, Vattikuti S, Lee CM et al. Acquired PTPN11 mutations occur rarely in adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Res 2005; 29: 459–462.
5. Quesnel B, Preudhomme C, Vanrumbeke M, Vachee A, Lai JL, Fenaux P . Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia. Leukemia 1994; 8: 878–880.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献